Its normal to be obese, said Tony Bashall, MD, a cardiologist at Franciscan Health Indiana Heart Physicians with an interest in cardiometabolic health
The difference likely reflects underlying metabolic differences, concurrent medications, and disease severity rather than any differential drug effect
The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks Weight loss was just the beginning: How the GLP-1 story is evolving Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity Ozempic and other new diabetes drugs revolutionize kidney treatment Three types of diabetes medication are improving the outlook for patients with kidney disease
The circumventricular organs actually express high levels of GLP1 receptors (Cork et al., 2015
Buyer Takeaway: Standard GLP-1 eligibility thresholds are BMI 30, or BMI 27 with a qualifying comorbidity
The rising prevalence of type 2 diabetes and obesity, innovations such as oral formulations and long-acting drugs, increased patient awareness, and regulatory approvals drive the GLP-1 Analogues market
